drug_type
RELEVANT_DRUG
intervention_type
Biologic drug (bispecific T-cell–engaging antibody)
drug_description
A subcutaneous bispecific T-cell–engaging antibody that binds BCMA on malignant plasma cells and CD3 on T cells to redirect T-cell cytotoxicity.
nci_thesaurus_definition
NCI thesaurus definition not available.
drug_category
BISPECIFIC T ENGAGER
drug_class
Engager
drug_delivery_route
Subcutaneous
drug_mechanism_of_action
Bispecific T‑cell–engaging antibody that binds BCMA on myeloma cells and CD3 on T cells, forming an immunologic synapse to activate T cells and induce targeted cytotoxic killing of BCMA‑expressing plasma cells.
drug_name
Elranatamab (PF-06863135)
nct_id_drug_ref
NCT06215118